A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer
一项多中心、随机、开放标签、双制剂、交叉生物等效性试验,旨在评估盐酸多柔比星脂质体注射液在中国转移性乳腺癌患者中的疗效。
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-025-06086-0
Wang, Jingshu; Lai, Xiuping; Yao, Herui; Yang, Hui; Cao, Xiaolong; Wang, Xiaochen; Wang, Ying; Nian, Weiqi; Zheng, Xiaodong; Mai, Qingxiu; Liu, Anding; Lv, Xiaozhi; Bi, Xiaoying; Chen, Junyi; Wu, Junyan; Ye, Suiwen